Article Details

Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B

Retrieved on: 2023-10-23 19:22:15

Tags for this article:

Click the tags to see associated articles and topics

Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B. View article details on HISWAI: https://www.beckershospitalreview.com/pharmacy/roche-to-buy-autoimmune-drugmaker-from-pfizer-roivant-for-7b.html

Excerpt

Roche has agreed to acquire Telavant Holdings, maker of an inflammatory bowel disease drug, from Roivant Sciences and Pfizer for $7.25 billion.

Article found on: www.beckershospitalreview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up